Clinical trials
Active, not recruiting Phase 3 Hemophilia A trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hangzhou Gensciences Biopharmaceutical Co., Ltd. | 2 |
| Novo Nordisk A/S | 2 |
| Pfizer | 2 |
| BioMarin Pharmaceutical | 1 |
| Bioverativ, a Sanofi company | 1 |
| CSL Behring | 1 |
| Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 1 |
| Hoffmann-La Roche | 1 |
| Jiangsu BioJeTay Biotechnology Co., Ltd. | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia A | 13 |
| Hematologic Diseases | 2 |
| Blood Coagulation Disorders | 1 |
| Blood Coagulation Disorders, Inherited | 1 |
| Coagulation Protein Disorders | 1 |
| Genetic Diseases, Inborn | 1 |
| Hemophilia B | 1 |
| Hemorrhagic Disorders | 1 |
| Hemostatic Disorders | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.